Cite
HARVARD Citation
Wang, G. et al. (2019). Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma. International journal of cancer. 145 (4), pp. 979-993. [Online].